Researchers Develop Automated Liquid Biopsy Test That Can Detect Cancer DNA In Blood Of Patients With Metastatic Breast Cancer Within Five Hours

Healio (8/12, Byrne) reported researchers “have developed an automated liquid biopsy test that can detect cancer DNA in the blood of patients with metastatic breast cancer within 5 hours.” The tool dubbed “Liquid Biopsy for Breast Cancer Methylation (LBx-BCM) works with a currently available molecular testing platform, GeneXpert (Cepheid), and can detect methylation in one or more of nine genes modified in breast cancer in 4.5 hours.” The tool was detailed in Cancer Research Communications.